1000005640

Neuland Laboratories

12300.00
-779.00 (-5.96%) tick NSE

Last updated on 25 Apr 2025 03:33 PM

Returns
-6.11%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

16787.01

Earning Per Share

232.24

Dividend Yield

0.22%

P/E Ratio

27.05

P/B Ratio

12.10

Debt to Equity

0.10

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Incorporated on January 7, 1984, Neuland Laboratories Limited (NLL) is promoted by Davuluri Sucheth Rao. The Company is engaged in manufacturing and selling of bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. Neuland Drugs & Pharmaceuticals Pvt. Ltd., a company set up by the same promoters to manufacture bulk drugs was merged with the Company effective from April, 1992. NLL manufactures bulk drugs.

Similar Companies